FilingsTodayElevance Health
At a glance
Elevance Health reported 2025 revenue of $199.13B, up 12.5% from $177.01B in 2024. Over 4 years since 2021 ($138.64B), that is growth of about 9.5% a year. Operating margin was 3.6%, down from 5.5% in 2021. 2025 was the highest revenue year in this period.
In the last 12 months 8 insiders reported 3 open-market purchases ($2.2M) and 6 sales ($6.4M). None of the sales were flagged as 10b5-1 plan trades. The largest was a sale of $4.7M by EVP & CFO Mark Kaye on Oct 23, 2026. Net, insiders were sellers of $4.2M.
Elevance Health filed 12 current reports (Form 8-K) in the last 12 months, most often for results of operations (4), regulation fd disclosure (4), officer or director change (2) and shareholder vote results (1). The latest officer or director change was reported on Feb 26, 2026.
Annual results
| Year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net income | $6.16B | $5.89B | $5.99B | $5.98B | $5.66B |
| Diluted EPS | $24.95 | $24.28 | $25.22 | $25.68 | $25.21 |
| Dividend per share | $4.52 | $5.12 | $5.92 | - | - |
Fiscal year ends Dec 31 · incorporated in IN
Current reports (8-K, last 12 months)
Insider open-market trades (last 12 months)
Source: SEC EDGAR. How figures are combined